FIBROGEN INC
For the period ended Dec 31, 2023. Filed Feb 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 26, 2024
KYNB$3.57-8.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity (Deficit)
(In thousands, except share data)
| Common Stock · Additional Paid-in · AccumulatedOtherComprehensive · Accumulated · NonControlling · Total · RedeemableNon-Controlling | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Capital | Loss | Deficit | Interests | Equity (Deficit) | Interests | |
| (Note 4) | ||||||||
| Balance at December 31, 2020 | 91,440,633 | $914 | $1,399,774 | $(4,499) | $(974,011) | $19,271 | $441,449 | $— |
| Net loss | — | — | — | — | (290,023) | — | (290,023) | — |
| Change in unrealized gain or loss on investments | — | — | — | (899) | — | — | (899) | — |
| Foreign currency translation adjustments | — | — | — | 1,235 | — | — | 1,235 | — |
| Shares issued from stock plans, net of payroll taxes paid | 1,439,900 | 15 | 5,479 | — | — | — | 5,494 | — |
| Stock-based compensation | — | — | 71,161 | — | — | — | 71,161 | — |
| Conversion of subsidiary’s convertible note payable (Note 13) | — | — | — | — | — | 696 | 696 | — |
| Balance at December 31, 2021 | 92,880,533 | $929 | $1,476,414 | $(4,163) | $(1,264,034) | $19,967 | $229,113 | $— |
| Net loss | — | — | — | — | (293,654) | — | (293,654) | — |
| Change in unrealized gain or loss on investments | — | — | — | (1,632) | — | — | (1,632) | — |
| Foreign currency translation adjustments | — | — | — | 75 | — | — | 75 | — |
| Shares issued from stock plans, net of payroll taxes paid | 1,285,553 | 13 | (996) | — | — | — | (983) | — |
| Stock-based compensation | — | — | 65,601 | — | — | — | 65,601 | — |
| Balance at December 31, 2022 | 94,166,086 | $942 | $1,541,019 | $(5,720) | $(1,557,688) | $19,967 | $(1,480) | $— |
| Net loss | — | — | — | — | (284,232) | — | (284,232) | — |
| Consolidation of Fortis (Note 4) | — | — | — | — | — | 520 | 520 | 21,480 |
| Change in unrealized gain or loss on investments | — | — | — | 2,557 | — | — | 2,557 | — |
| Foreign currency translation adjustments | — | — | — | (3,712) | — | — | (3,712) | — |
| Issuance of common stock under ATM Program | 2,472,090 | 24 | 48,383 | — | — | — | 48,407 | — |
| Shares issued from stock plans, net of payroll taxes paid | 2,132,071 | 22 | 3,472 | — | — | — | 3,494 | — |
| Stock-based compensation | — | — | 50,767 | — | — | — | 50,767 | — |
| Balance at December 31, 2023 | 98,770,247 | $988 | $1,643,641 | $(6,875) | $(1,841,920) | $20,487 | $(183,679) | $21,480 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.